| High-throughput, machine learning–based quantification of steatosis, inflammation, ballooning, and fibrosis in biopsies from patients with nonalcoholic fatty liver disease R Forlano, BH Mullish, N Giannakeas, JB Maurice, N Angkathunyakul, ... Clinical Gastroenterology and Hepatology 18 (9), 2081-2090. e9, 2020 | 107 | 2020 |
| In-hospital mortality is associated with inflammatory response in NAFLD patients admitted for COVID-19 R Forlano, BH Mullish, SK Mukherjee, R Nathwani, C Harlow, P Crook, ... PLoS One 15 (10), e0240400, 2020 | 62 | 2020 |
| Current and future pharmacological therapies for managing cirrhosis and its complications D Kockerling, R Nathwani, R Forlano, P Manousou, BH Mullish, A Dhar World Journal of Gastroenterology 25 (8), 888, 2019 | 62 | 2019 |
| Clinical characteristics and predictors of outcomes of hospitalized patients with COVID-19 in a multi-ethnic London NHS Trust: a retrospective cohort study PN Perez-Guzman, A Daunt, S Mukherjee, P Crook, R Forlano, MD Kont, ... Clin Infect Dis 7, ciaa1091, 2020 | 55 | 2020 |
| Quantification of liver fibrosis—A comparative study A Arjmand, MG Tsipouras, AT Tzallas, R Forlano, P Manousou, ... Applied Sciences 10 (2), 447, 2020 | 40 | 2020 |
| Derivation and validation of a cardiovascular risk score for prediction of major acute cardiovascular events in non‐alcoholic fatty liver disease; the importance of an elevated … RD Abeles, BH Mullish, R Forlano, T Kimhofer, M Adler, A Tzallas, ... Alimentary pharmacology & therapeutics 49 (8), 1077-1085, 2019 | 38 | 2019 |
| Training of deep convolutional neural networks to identify critical liver alterations in histopathology image samples A Arjmand, CT Angelis, V Christou, AT Tzallas, MG Tsipouras, E Glavas, ... Applied Sciences 10 (1), 42, 2019 | 35 | 2019 |
| Clinical characteristics and predictors of outcomes of hospitalized patients with coronavirus disease 2019 in a multiethnic London national health service trust: a … PN Perez-Guzman, A Daunt, S Mukherjee, P Crook, R Forlano, MD Kont, ... Clinical Infectious Diseases 73 (11), e4047-e4057, 2021 | 34 | 2021 |
| The intestinal barrier and its dysfunction in patients with metabolic diseases and non-alcoholic fatty liver disease R Forlano, BH Mullish, LA Roberts, MR Thursz, P Manousou International journal of molecular sciences 23 (2), 662, 2022 | 24 | 2022 |
| Report 17: Clinical characteristics and predictors of outcomes of hospitalised patients with COVID-19 in a London NHS Trust: a retrospective cohort study PN Perez-Guzman, A Daunt, S Mukherjee, P Crook, R Forlano, MD Kont, ... Imperial College London, 2020 | 23 | 2020 |
| Non-alcoholic fatty liver disease and vascular disease R Forlano, BH Mullish, R Nathwani, A Dhar, MR Thursz, P Manousou Current vascular pharmacology 19 (3), 269-279, 2021 | 21 | 2021 |
| Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients P Agosti, M Tettamanti, FS Vella, P Suppressa, L Pasina, C Franchi, ... European Journal of Internal Medicine 57, 25-31, 2018 | 19 | 2018 |
| A review of liver fibrosis and emerging therapies R Nathwani, BH Mullish, D Kockerling, R Forlano, P Manousou, A Dhar EMJ Hepatology 4.4 2019 4 (4), 105-116, 2020 | 18 | 2020 |
| Deep learning in liver biopsies using convolutional neural networks A Arjmand, CT Angelis, AT Tzallas, MG Tsipouras, E Glavas, R Forlano, ... 2019 42nd International Conference on Telecommunications and Signal …, 2019 | 18 | 2019 |
| Appropriateness of antiplatelet therapy for primary and secondary cardio‐and cerebrovascular prevention in acutely hospitalized older people I Ardoino, R Rossio, D Di Blanca, A Nobili, L Pasina, PM Mannucci, ... British journal of clinical pharmacology 83 (11), 2528-2540, 2017 | 18 | 2017 |
| Gut microbiota—a future therapeutic target for people with non-alcoholic fatty liver disease: a systematic review R Forlano, M Sivakumar, BH Mullish, P Manousou International Journal of Molecular Sciences 23 (15), 8307, 2022 | 12 | 2022 |
| Transfer learning versus custom CNN architectures in NAFLD biopsy images A Arjmand, V Christou, AT Tzallas, MG Tsipouras, CT Angelis, ... 2020 43rd International Conference on Telecommunications and Signal …, 2020 | 12 | 2020 |
| Non-alcoholic fatty liver disease and cardiovascular risk: an update BH Mullish, R Forlano, P Manousou, DP Mikhailidis Expert Review of Gastroenterology & Hepatology 12 (12), 1175-1177, 2018 | 11 | 2018 |
| Liver function tests and metabolic-associated fatty liver disease: Changes in upper normal limits, does it really matter? R Forlano, BH Mullish, A Dhar, RD Goldin, M Thursz, P Manousou World Journal of Hepatology 13 (12), 2104, 2021 | 9 | 2021 |
| NAFLD: Time to apply quantitation in liver biopsies as endpoints in clinical trials R Forlano, BH Mullish, JB Maurice, MR Thursz, RD Goldin, P Manousou Journal of Hepatology 74 (1), 241-242, 2021 | 8 | 2021 |
